The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has made a public disclosure concerning its interest in Spire Healthcare Group plc, as per Rule 8.3 of the UK Takeover Code. Disclosed on February 2, 2026, the submission includes the firm's position as of January 30, 2026. Vanguard is a significant stakeholder, holding 3.58% of Spire's 1p ordinary shares, totaling 14,423,747 shares.

Recent transactions by Vanguard include the purchase of 2,368 shares at 2.05 GBP each and 6,906 shares at 2.07 GBP each. No cash-settled derivative transactions or stock-settled derivative activities involving options were reported.

Vanguard has confirmed the absence of any informal or formal agreements linked to securities. Furthermore, there are no indemnity arrangements or commitments noted in the disclosure.